Christian Nilewski

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Venues

ACS medicinal chemistry letters

Organic letters

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Nilewski, Sharada Labadie, Binqing Wei, Sushant Malhotra, Steven Do, Lewis Gazzard, Li Liu, Cheng Shao, Jeremy Murray, Yevgeniy Izrayelit, Amy Gustafson, Nicholas F Endres, Fang Ma, Xin Ye, Jun Zou, Marie Evangelista
Structure-Based Design and Evaluation of Reversible KRAS G13D Inhibitors. ACS medicinal chemistry letters 15 (1) (2023)
Christian Nilewski, Sharada Labadie, Binqing Wei, Sushant Malhotra, Steven Do, Lewis Gazzard, Li Liu, Cheng Shao, Jeremy Murray, Yevgeniy Izrayelit, Amy Gustafson, Nicholas F Endres, Fang Ma, Xin Ye, Jun Zou, Marie Evangelista
Structure-Based Design and Evaluation of Reversible KRAS G13D Inhibitors. ACS medicinal chemistry letters 15 (1) (2023)
Peggy A Thompson, Boreth Eam, Nathan P Young, Sarah Fish, Joan Chen, Maria Barrera, Haleigh Howard, Eric Sung, Ana Parra, Jocelyn Staunton, Gary G Chiang, Adina Gerson-Gurwitz, Christopher J Wegerski, Andres Nevarez, Jeff Clarine, Samuel Sperry, Alan Xiang, Christian Nilewski, Garrick K Packard, Theodore Michels, Chinh Tran, Paul A Sprengeler, Justin T Ernst, Siegfried H Reich, Kevin R Webster
Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A. Molecular cancer therapeutics 20 (1) (2020)
Christian Nilewski, Theodore D Michels, Alan X Xiang, Garrick K Packard, Paul A Sprengeler, Boreth Eam, Sarah Fish, Peggy A Thompson, Christopher J Wegerski, Justin T Ernst, Siegfried H Reich
Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A Inhibitors. Organic letters 22 (16) (2020)

Christian Nilewski.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christian Nilewski